The Food and Drug Administration (FDA) has granted approval for Eli Lilly's highly anticipated obesity treatment, marking a significant development in the pharmaceutical industry. As experts predict, this breakthrough medicine is expected to become one of the highest-grossing drugs in history. Zepbound: An Obesity Treatment with a Promising Future Previously known as Mounjaro … [Read more...] about A Game-Changer in Obesity Treatment: The FDA Approves Eli Lilly’s Zepbound
Virgin Galactic Reports Narrowed Quarterly Loss and Increased Revenue
Virgin Galactic Holdings Inc. shares experienced a surge in the after-hours session on Wednesday after the space-tourism company announced a narrowing of its quarterly loss and a significant increase in revenue. Improvements in Financial Performance In the third quarter, Virgin Galactic reduced its losses to $105 million, or 28 cents a share, compared to $146 million, or 55 … [Read more...] about Virgin Galactic Reports Narrowed Quarterly Loss and Increased Revenue
Social Security’s Pending Insolvency: Potential Solutions Discussed
The issue of Social Security's pending insolvency took center stage at the recent Republican presidential debate. Several candidates expressed their willingness to consider raising the full retirement age, particularly for young individuals just starting their careers. Recognizing the Need for Change Former New Jersey Governor Chris Christie emphasized the importance of raising … [Read more...] about Social Security’s Pending Insolvency: Potential Solutions Discussed
Wuxi XDC Cayman: Strong Demand for IPO in Hong Kong
A unit of Chinese contract drugmaker Wuxi Biologics has experienced overwhelming demand for its initial public offering (IPO) in Hong Kong, closing its order book early and potentially pricing the deal at the top of its marketed range, according to sources familiar with the matter. This is a remarkable occurrence in a year that has seen a turbulent market for listings in Hong … [Read more...] about Wuxi XDC Cayman: Strong Demand for IPO in Hong Kong
Oil Futures Bounce Back Despite Weak Chinese Demand
Oil futures rebounded on Thursday after a two-day drop, ignoring data that indicated weak consumer demand in China. Despite the setback, crude prices attempted to recover, reaching their lowest level since mid-July. Price Action West Texas Intermediate crude for December delivery rose by 54 cents, or 0.4%, to $75.87 a barrel on the New York Mercantile Exchange. January Brent … [Read more...] about Oil Futures Bounce Back Despite Weak Chinese Demand
